Provided by Tiger Trade Technology Pte. Ltd.

Black TITAN Corp

0.6010
-0.0097-1.59%
Post-market: 0.5662-0.0348-5.79%19:59 EDT
Volume:1.89M
Turnover:1.10M
Market Cap:6.48M
PE:0.83
High:0.6300
Open:0.5670
Low:0.5670
Close:0.6107
52wk High:39.00
52wk Low:0.5364
Shares:10.77M
Float Shares:4.81M
Volume Ratio:0.24
T/O Rate:39.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7205
EPS(LYR):0.3057
ROE:--
ROA:--
PB:6.45
PE(LYR):1.97

Loading ...

Company Profile

Company Name:
Black TITAN Corp
Exchange:
NASDAQ
Establishment Date:
1990
Employees:
- -
Office Location:
The Bousteador,Level 8, Unit 802,10 Jalan PJU 7/6,Mutiara Damansara,Petaling Jaya,Selangor,Malaysia
Zip Code:
47800
Fax:
- -
Introduction:
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases in the United States and internationally. It develops products based on ProNeura, a proprietary long-term drug delivery platform. It also develops TP-2021 in combination with ProNeura technology for the treatment of chronic pruritus, a severe and debilitating condition defined as itching of the skin lasting longer than six weeks; and Nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder. The company was founded in 1991 and is based in South San Francisco, California.

Directors

Name
Position
Brynner Chiam
Chief Financial Officer and Director and Co-Chief Executive Officer
Avraham Ben Tzvi
Independent Director
Farduz Edmin Bin Mokhtar
Independent Director
Francisco Osvaldo Flores Garcia
Independent Director
Gabriel Loh
Independent Director

Shareholders

Name
Position
Brynner Chiam
Chief Financial Officer and Director and Co-Chief Executive Officer
Shang Ju Lin
Co-Chief Executive Officer